Nystatin Profile on Candida Species in HIV/AIDS Patients with Oral Candidiasis: A Phenomenology Study

Oral candidiasis is the main symptom that often appears in patients with Human Immunodeficiency Virus (HIV) / Acquired Immune Syndrome (AIDS). Recent studies reported that some bacteria causing oral candidiasis are resistant to antifungal drugs. Describing nystatin profile against candida species in...

Full description

Bibliographic Details
Main Authors:	Dwi Murtiastutik, Cut Shelma Maharani, Rahmadewi, Muhammad Yulianto Listiawan
Format:	Article
Language:	English
Published:	Journal of Pure and Applied Microbiology 2019-12-01
Series:	Journal of Pure and Applied Microbiology
Subjects:	nystatin fluconazole oral candidiasis candida albicans hiv/aids
Online Access:	https://microbiologyjournal.org/nystatin-profile-on-candida-species-in-hiv-aids-patients-with-oral-candidiasis-a-phenomenology-study/

Similar Items

Antifungal Activity of Rosmarinus Officinalis Essential Oil and Nystatin on Store Isolate of Candida species from HIV/AIDS Patients with Oral Candidiasis
by: Bernadya Yogatri Anjuwita, et al.
Published: (2020-11-01)

In Vitro Comparison of Antifungal Activity between Epigallocatechin Gallate EGCG) and Nystatin on Candida Sp. Stored Isolates in HIV/AIDS Patients with Oral Candidiasis
by: Yusuf Wibisono, et al.
Published: (2021-07-01)

Sensibility Test of Candida species against Nystatin, Ketoconazole, and Fluconazole on Oral Candidiasis with HIV/AIDS using Disc Diffusion Method
by: Cut Shelma Maharani, et al.
Published: (2020-11-01)

Comparison of antifungal effects of an experimental fluconazole mouthwash and nystatine mouthwash: An in vitro study
by: Nader Navabi, et al.
Published: (2013-01-01)

Compare resistance and antifngal effects of Fluconazole, Itraconazole , Ketoconazole and nystatin on ( Candida albicans) isolated from Vulvovaginitis in Qom in 1395
by: Ameneh basem hamid, et al.
Published: (2018-09-01)

In vitro interactions of nystatin and micafungin combined with chlorhexidine against Candida albicans isolates
by: Maede Salehi, et al.
Published: (2022-03-01)

In Vitro Antifungal Susceptibility Testing of Tea Tree Oil (TTO) 5% Compared with Nystatin against Candida sp. as Important Agent of Oral Candidiasis in HIV/AIDS Patients
by: Eva Lydiawati, et al.
Published: (2020-11-01)

The inhibitory effects of carvacrol, nystatin, and their combination on oral candidiasis isolates
by: Seyed Saeed Hosseini Balef, et al.
Published: (2024-04-01)

Antifungal Activity of Rosemary (Rosmarinus officinalis L.) Emulsion Gel Compared to Nystatin on Candida albicans Stored Isolate from HIV/AIDS Patients with Oral Candidiasis
by: Maya Wardiana, et al.
Published: (2023-07-01)

Comparison of Antifungal Susceptibility Basil Leaves Extract (Ocimum sanctum Linn.), Eugenol, and Nystatin against Isolates of Candida spp. as Important Agent causing Oral Candidiasis in HIV/AIDS Patient
by: Emma Hidayati Sasmito, et al.
Published: (2022-11-01)

Inhibitory effects of different fractions separated from standardized extract of Myrtus communis L. against nystatin-susceptible and nystatin-resistant Candida albicans isolated from HIV positive patients
by: Iman Torabi, et al.
Published: (2022-03-01)

A comparison of the efficacy of nystatin and fluconazole incorporated into tissue conditioner on the in vitro attachment and colonization of Candida Albicans
by: Abbas Falah-Tafti, et al.
Published: (2010-01-01)

Association between etiologic species with CD4 count and clinical features of oral candidiasis among HIV/AIDS patients
by: Dwi Murtiastutik, et al.
Published: (2022-01-01)

The comparison of the effect of curcumin with nystatin on inhibition level of Candida albicans
by: Nosratzehi T, et al.
Published: (2019-08-01)

In Vitro Effects of Propolis Mouthwash and Nystatin on Candida Albicans: A Comparative Study
by: Mohammad Sadegh Alemrajabi, et al.
Published: (2021-11-01)

Comparison of the Effect of Ginger and Nystatin Mouthwash on the Growth of Candida Albicans under in Vitro Conditions
by: K Ghods, et al.
Published: (2022-03-01)

Efficacy of different formulations of nystatin in an experimental model of oral candidiasis in sialoadenectomized rats
by: Mario Pérez-Sayáns, et al.
Published: (2021-01-01)

Inhibitory Effect of Aqueous Salvia officinalis’s leaves in the Growth of Candida albicans from Infected Women with Vaginal Candidiasis
by: Rusul Mohammad jasim, et al.
Published: (2011-06-01)

Identification of Candida Species and Antifungal Susceptibility in Cancer Patients with Oral Lesions in Ahvaz, Southern West of Iran
by: Mehrnoush Maheronnaghsh, et al.
Published: (2020-01-01)

Effect of Thymus vulgaris, Myrtus communis and nystatin on Candida albicans
by: Zia MA, et al.
Published: (2013-11-01)

Antifungal Activity of Lavandula Angustifolia and Quergues Infectoria Extracts in Comparison with Nystatin on Candida Albicans
by: F. Nouri, et al.
Published: (2016-09-01)

Fluconazole Resistant Oral Candidiasis on HIV Patient - What Other Drug can We Choose? A Case Report
by: Dwi Murtiastutik, et al.
Published: (2020-03-01)

Three cases of vulvovaginal candidiasis due to Candida nivariensis
by: Phuong Anh Ton Nu, et al.
Published: (2024-03-01)

Vulvovaginal candidiasis therapy in reproductive age women
by: Т. Г. Романенко, et al.
Published: (2020-10-01)

Antifungal resistance profile in the treatment of vaginal candidiasis: A diagnosis of etiologic agents
by: Lisbeth Roxana Herreras Gomez, et al.
Published: (2022-04-01)

Efficacy of nystatin for the treatment of oral candidiasis: a systematic review and meta-analysis
by: Lyu X, et al.
Published: (2016-03-01)

A High Rate of Recurrent Vulvovaginal Candidiasis and Therapeutic Failure of Azole Derivatives Among Iranian Women
by: Amir Arastehfar, et al.
Published: (2021-04-01)

Prevalencia de Candida albicans y Candida no albicans en diferentes muestras clínicas: Período 1999-2001 Prevalence of Candida albicansand Candida no albicans inclinical samples during 1999-2001
by: M.T. Mujica, et al.
Published: (2004-09-01)

Comparison of Fluconazole and Clotrimazole in the Treatment of Acute Candida Albicans Vulvovaginitis
by: Fatemeh Bahadori, et al.
Published: (2008-12-01)

Antifungal Susceptibility of Oral <i>Candida</i> Isolates from Mother-Infant Dyads to Nystatin, Fluconazole, and Caspofungin
by: Naemah Alkhars, et al.
Published: (2023-05-01)

Antifungal susceptibility testing of vulvovaginal Candida species among women attending antenatal clinic in tertiary care hospitals of Peshawar
by: Khan M, et al.
Published: (2018-03-01)

Comparison of Antifungal Efficacy of Zataria Multiflora and Nystatin for Treatment of Denture Stomatitis: A Randomized Clinical Trial
by: Elnaz Gonoudi, et al.
Published: (2021-03-01)

Treatment of Vaginal Candidiasis by Ethanolic Extract of Propolis in Rabbit
by: A Ownagh, et al.
Published: (2012-08-01)

Preparation and Characterization of Mucoadhesive Tablets Containing Nystatin for Treatment of Oral Candidiasis
by: Fatemeh Ahmadi, et al.
Published: (2020-06-01)

Considerations of Nystatin Roll in Oral Candidiasis Scenario and the COVID-19 Pandemic—A Review
by: Michelle Maria Gonçalves Barão de Aguiar, et al.
Published: (2023-11-01)

Efficacy of oral nystatin treatment for patients with oral mucosal dysesthesia but without objective oral mucosal manifestations and necessity of Candida culture test before oral nystatin treatment
by: Ding-Shan Peng, et al.
Published: (2022-10-01)

Isolated pulmonary candidiasis in a patient with diabetes mellitus: A rare case report
by: Atousa Hakamifard, et al.
Published: (2016-01-01)

Antifungal effect of the bark and root extracts of Punica granatum on oral Candida isolates
by: Fatemeh Lavaee, et al.
Published: (2018-12-01)

Interspecies differences of candida species causing recurrent vulvovaginal candidiasis in response to fluconazole treatment
by: Siamak Naji, et al.
Published: (2017-07-01)

Prevalence of Candida albicans and non-albicans isolates from vaginal secretions: comparative evaluation of colonization, vaginal candidiasis and recurrent vaginal candidiasis in diabetic and non-diabetic women
by: Luciene Setsuko Akimoto Gunther, et al.